
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Jorge E Gomez, MD
Internal Medicine, Cancer (Oncology)
About Me
Jorge Gomez, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai and Medical Director of the solid tumor oncology inpatient unit at The Mount Sinai Hospital. He is also Medical Director of Mount Sinai’s World Trade Center Oncology Clinic, serving as medical oncology liaison for patients with cancer potentially caused by events of September 11, 2001. Dr. Gomez has been at Mount Sinai since 2012 and has been practicing medicine since 1997.
Dr. Gomez specializes in the treatment of patients with lung cancer. He has a particular interest in the treatment and study of lung cancer in patients who have never smoked and in the improvement of outcomes for patients with locally advanced disease through the development of better multimodality therapies. Dr. Gomez conducts research on the incorporation of new therapeutic agents into the standard treatment of lung cancer through clinical trials. He also focuses on identifying subpopulations of patients with lung cancer whose tumors may harbor driver mutations that can be targeted for treatment.
Dr. Gomez is a volunteer Lung Cancer Spokesperson and Expert Medical Advisory Panel Member for the American Lung Association.
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Lung Cancer
Video
Education
MD, Universidad de Caldas
Residency, Internal Medicine
Pennsylvania Hospital
Fellowship, Hematology & Oncology
New York University School of Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- 32BJ Health Fund
- AETNA - Commercial
- AETNA - Medicare
- Amidacare Medicaid
- Anthem/Empire Blue Cross Blue Shield - Commercial
- Anthem/Empire Blue Cross Blue Shield - HealthPlus Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Surgical outcomes and quality of life in octogenarians with early-stage non-small cell lung cancer: a prospective cohort study. Louis Gros, Rowena Yip, Wenchao Ma, Jeffrey Zhu, Jiafang Zhang, Sydney Kantor, Siyang Cai, Andrew J. Kaufman, Andrea S. Wolf, Ardeshir Hakami-Kermani, Daniel Nicastri, Dong Seok Lee, Kimberly J. Song, Brian Housman, David F. Yankelevitz, Emanuela Taioli, Claudia I. Henschke, Raja M. Flores, Raja Flores, Andrew J. Kaufman, Dong Seok Daniel Lee, Daniel Nicastri, Andrea Wolf, Kimberly Song, Kenneth Rosenzweig, Robert Samstein, Pinaki Dutta, Jorge Gomez, Mary Beth Beasley, Maureen Zakowski, Michael Chung, David F. Yankelevitz, Claudia I. Henschke, Emanuela Taioli, Yeqing Zhu, Natela Paksashvili, Lijing Zhang, Lyu Lyu, Huiwen Chan, Jeffrey Zhu, Sydney Kantor, Lauren Lentini, Daniel Nicastri, Ardeshir Hakami-Kermani, Arzu Buyuk, Ardeshir Hakami-Kermani, Raja Flores, Emanuela Taioli, Rebecca Schwartz, Artit Jirapatnakul. The Lancet Regional Health - Americas
- Antibody drugs conjugates in non–small cell lung cancer: current status and challenges. Arjun Syal, May Lucie Meyer, Kenneth Angelino, Noah Osei, Jorge E. Gomez, Triparna Sen, Fred R. Hirsch. Oncologist
- Antibody drugs conjugates in small-cell lung cancer: present-day status and promises. Arjun Syal, May Lucie Meyer, Kenneth Angelino, Noah Osei, Jorge E. Gomez, Fred R. Hirsch, Triparna Sen. Oncologist
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Gomez during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services
Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership- Nuvation Bio
- Lilly USA, LLC
- Regeneron Pharmaceuticals, Inc.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.